Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
38 results
D1.151 - Changes in Treatment Steps After Biological Therapy in Patients with Severe Asthma: Real-World Data
D1.139 - Dupilumab was Effective in Black and Non-Black Patients with Asthma Completing 1 Year of the RAPID Registry
D1.140 - Beyond Severe Asthma: Eosinophilic Granulomatosis with Polyangiitis Unmasked by Acute Myopericarditis
D1.141 - Added value of impulse oscillometry in the early detection of small airway dysfunction in asthma
D1.142 - Clinical remission in long-term biological therapy of severe asthma
D1.143 - Clinical Efficacy of Biologics and ATAD in NSAID-Exacerbated Respiratory Disease: A Phenotype-Based Comparative Study
D1.144 - Eosinophilic myocarditis as a complication of dupilumab treatment
D1.145 - Clinical Impact of Type 2 Phenotype in Severe Asthma Patients with Exacerbations During Biologic Treatment
D1.146 - Improved nocturnal oxygenation in a severe allergic asthma patient with comorbid sleep apnea under anti-TSLP biologic therapy
D1.147 - Efficacy of benralizumab in Chinese patients with severe eosinophilic asthma: subgroup analysis of the 16-week results from STEP, a phase IIIb study of step-down maintenance therapy
D1.148 - Real-world effectiveness of dupilumab administered every 4 weeks in patients with moderate to severe asthma
D1.149 - Healthcare Professionals Typically Apply Higher Blood Eosinophil Count Thresholds for Biologic Selection Versus Clinical Guidelines in Severe Asthma
D1.150 - Patient characteristics and treatment patterns in adults with severe asthma in Poland (POLSAR): a retrospective, single-center real-world cohort from ISAR
D1.152 - Treatment-induced remission after mepolizumab discontinuation: case series
D1.153 - Indirect Comparison of Biological Agents in Severe Asthma: Real-World Data
D3.121 - Evaluation of small airway dysfunction in severe asthma treated with anti-IgE and anti-eosinophilic therapies: A prospective comparative study
D3.109 - Clinical Characteristics of Asthma Patients with Fungal Sensitization: A Retrospective Cross-Sectional Study
D3.110 - Patterns of Opioid or Neuromodulator Use in Chronic Cough Patients with Newly Diagnosed Asthma
D3.111 - The Impact of War on the Course of Asthma
D3.112 - Clinical Characteristics and Evaluation of Serum Inflammatory Markers in Patients Hospitalized Due to Asthma Exacerbations
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download